A novel NLRP7 protein-truncating mutation associated with discordant and divergent p57 immunostaining in diploid biparental and triploid digynic moles

Virchows Arch. 2020 Aug;477(2):309-315. doi: 10.1007/s00428-020-02769-w. Epub 2020 Feb 13.

Abstract

NLRP7 is a maternal-effect gene that has a primary role in the oocyte. Its biallelic mutations are a major cause for recurrent diploid biparental hydatidiform moles (HMs). Here, we describe the full characterization of four HMs from a patient with a novel homozygous protein-truncating mutation in NLRP7. We found that some HMs have features of both complete and partial moles. Two HMs expressed p57 in the cytotrophoblast and stromal cells and exhibited divergent and discordant immunostaining. Microsatellite DNA-genotyping demonstrated that two HMs are diploid biparental and one is triploid digynic due to the failure of meiosis II. FISH analysis demonstrated triploidy in the cytotrophoblast and stromal cells in all villi. Our data highlight the atypical features of HM from patients with recessive NLRP7 mutations and the important relationship between NLRP7 defects in the oocyte and p57 expression that appear to be the main contributor to the molar phenotype regardless of the zygote genotype.

Keywords: Digynic triploidy; Genotyping; Mutation; NLRP7; Recurrent hydatidiform mole; p57.

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / metabolism*
  • Cyclin-Dependent Kinase Inhibitor p57 / metabolism*
  • Female
  • Genotype
  • Gestational Trophoblastic Disease
  • Humans
  • Hydatidiform Mole / genetics
  • Hydatidiform Mole / metabolism*
  • Mutation / genetics
  • Neoplasm Recurrence, Local / genetics
  • Neoplasm Recurrence, Local / metabolism*
  • Nevus, Pigmented / genetics
  • Phenotype
  • Pregnancy
  • Uterine Neoplasms / metabolism*

Substances

  • Adaptor Proteins, Signal Transducing
  • CDKN1C protein, human
  • Cyclin-Dependent Kinase Inhibitor p57
  • NLRP7 protein, human